| Autor: |
Abeygunawardena S; Research assistant, Sault Ste. Marie Academic Medical Association, Sault Ste. Marie, Ont., Kassen R; Professor, Department of Biology, University of Ottawa, Ottawa, Ont., Fralick M; Clinician scientist, Division of General Internal Medicine, Sinai Health System, Toronto, Ont. |
| Jazyk: |
angličtina |
| Zdroj: |
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [CMAJ] 2022 Nov 28; Vol. 194 (46), pp. E1575. |
| DOI: |
10.1503/cmaj.147480-l |
| Abstrakt: |
Competing Interests: Competing interests: The authors report funding from the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council (an alliance grant and a discovery grant), CoVaRR-Net (rapid response research grant), The Ottawa Hospital Academic Medical Organization, the University of Ottawa and the Northern Ontario Academic Medical Association. Mike Fralick reports being a consultant for ProofDx, a start-up company that has created a point-of-care test for SARS-CoV-2 using CRISPR gene editing technology. No other competing interests were declared. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
